Your browser doesn't support javascript.
loading
Hormonal contraception and HIV acquisition among women: an updated systematic review.
Curtis, Kathryn M; Hannaford, Philip C; Rodriguez, Maria Isabel; Chipato, Tsungai; Steyn, Petrus S; Kiarie, James N.
Afiliación
  • Curtis KM; Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA kmc6@cdc.gov.
  • Hannaford PC; Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Rodriguez MI; Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon, USA.
  • Chipato T; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
  • Steyn PS; Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
  • Kiarie JN; Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
BMJ Sex Reprod Health ; 46(1): 8-16, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31919239
OBJECTIVE: To update a 2016 systematic review on hormonal contraception use and HIV acquisition. METHODS: We searched Pubmed and Embase between 15 January 2016 and 26 June 2019 for longitudinal studies comparing incident HIV infection among women using a hormonal contraceptive method and either non-users or users of another specific hormonal contraceptive method. We extracted information from newly identified studies, assessed study quality, and updated forest plots and meta-analyses. RESULTS: In addition to 31 previously included studies, five more were identified; three provided higher quality evidence. A randomised clinical trial (RCT) found no statistically significant differences in HIV risk among users of intramuscular depot medroxyprogesterone acetate (DMPA-IM), levonorgestrel implant (LNG implant) or the copper intrauterine device (Cu-IUD). An observational study found no statistically significant differences in HIV risk among women using DMPA, norethisterone enanthate (NET-EN), implants (type not specified) or Cu-IUD. Updated results from a previously included observational study continued to find a statistically significant increased HIV risk with oral contraceptives and DMPA compared with no contraceptive use, and found no association between LNG implant and HIV risk. CONCLUSIONS: High-quality RCT data comparing use of DMPA, LNG implant and Cu-IUD does not support previous concerns from observational studies that DMPA-IM use increases the risk of HIV acquisition. Use of other hormonal contraceptive methods (oral contraceptives, NET-EN and implants) is not associated with an increased risk of HIV acquisition.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Anticoncepción Hormonal Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: BMJ Sex Reprod Health Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Anticoncepción Hormonal Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: BMJ Sex Reprod Health Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido